Vaccine supply and demand are about to flip

With 127 million “jabs” administered in America so far, and more manufacturers on their way to Food and Drug Administration approval, the market for vaccines is about to change very quickly. What happens to the holdouts? We’ll talk about it. But first, a bit of news on Facebook and online privacy. Plus, a new tool to get out of your Zoom meetings.

Here’s everything we talked about today:

• “U.S. Supreme Court rebuffs Facebook appeal in user tracking lawsuit” from Reuters
• “The US is about to reach a surprise milestone: too many vaccines, not enough takers” from MIT Technology Review
• “Congress passes bill to allow VA to vaccinate all vets, spouses, caregivers” from Stars and Stripes
• “How Much Weight Did We Gain During Lockdowns? 2 Pounds a Month, Study Hints” from The New York Times
• “Zoom Escaper lets you sabotage your own meetings with audio problems, crying babies, and more” from The Verge

Stories You Might Like

What are second-quarter results from companies telling us so far?

Giving out COVID vaccines is complicated, even within a single company

All these years later, policy is still catching up to Gamergate

Your COVID-19 vaccine was likely free — what about the booster?

AstraZeneca looks beyond vaccines but has no regrets, says CEO

These lawyers are suing over masks, vaccines and more